“…The increased PSA concentration is commonly suspected to be connected with prostate cancer or other prostate diseases. Recently, different methods have been reported for PSA detection, e.g., (electro-)chemiluminescence immunoassay, enzyme immunoassay, fluorescence immunoassay, electrochemical immunoassay and radioimmunoassay (RIA) (Xu et al, 2017;Shi et al, 2016;Acevedo et al, 2002;Shu et al, 2016;Zhuang et al, 2015;Graves et al, 1992). Despite the high sensitivity of conventional immunoassays such as RIA and ELISA, they have some limitations, such as the short shelf life of 125 I-labeled antibody, radiation hazards, low sensitivity and expensive instruments.…”